Here are four things to know about the company’s stock:
• The company presently has an average rating of “buy” and a consensus target price of $28.24.
• Globus Medical has a 52-week low of $17.45 and a 52-week high of $27.14.
• The stock’s 50-day moving average is $24.44 and its 200-day moving average is $22.
• The company has a market cap of $2.2 billion.
More articles on devices:
NuVasive’s 2014 revenue up 11.3% — 10 key notes
Medtronic Spine to honor Dr. Kenneth Robinson
ChoiceSpine brings former Alphatec, TranS1 execs onboard — 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
